Dynavax Technologies | Lucro Bruto Sobre Vendas



Gross Profit On Sales Alterar Data
AbbVie USD 9.34B 1.36B 2025-03
Adma Biologics USD 63.33M 3.67M 2024-12
Amgen USD 6.17B 624M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Dynavax Technologies USD 78.57M 24.17M 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
Glaxosmithkline GBP 5.6B 94M 2024-12
Merck USD 12.99B 224M 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 10.88B 248M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
TG Therapeutics USD 122.21M 16.9M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06


Dynavax Technologies Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.